首页> 外国专利> Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo

Transduced neoplastic cell preparations able to express T-cell costimulatory molecules B7.1, ICAM-1, and LFA-3 and induce immunostimulatory prophylactic and therapeutic anti-tumor effects in-vivo

机译:转导的肿瘤细胞制剂,能够表达T细胞共刺激分子B7.1,ICAM-1和LFA-3,并在体内诱导免疫刺激性预防和治疗性抗肿瘤作用

摘要

The present invention provides a neoplastic cell transduced by a TRICOM viral vector construct and a genetically altered neoplastic cellular preparation able to overexpress molecule B7.1, intracellular adhesion molecule-1 (ICAM-1) and leukocyte function-associated antigen-3 (LFA-3) as discrete products and costimulatory molecules. The TRICOM transduced neoplastic cells are useful in-vivo as a prophylactic vaccination to prevent the future generation of a tumor within a living mammalian subject; and also as a therapeutic anti-tumor agent effective against a pre-existing tumor then located at one or more anatomic sites within the body of a living mammalian patient.
机译:本发明提供了由TRICOM病毒载体构建体转导的肿瘤细胞和能够过表达分子B7.1,细胞内粘附分子-1(ICAM-1)和白细胞功能相关抗原-3(LFA-)的基因改变的肿瘤细胞制剂。 3)作为离散产物和共刺激分子。 TRICOM转导的赘生性细胞在体内可用作预防性疫苗接种,以防止在活的哺乳动物受试者中将来产生肿瘤。以及作为一种有效的抗肿瘤治疗剂,该抗肿瘤剂可有效地治疗已存在的哺乳动物,然后位于活着的哺乳动物患者体内的一个或多个解剖部位。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号